29th September 2019

TargetScape® – Identifying and Profiling the Cellular Immune Response

To develop immunotherapies for cancer, infectious diseases, autoimmune diseases and other disorders, a need exists for high-dimensional profiling to identify and better understand the role of antigen-specific T cells, the key effectors in many diseases. ImmunoScape’s TargetScape™ can screen and identify antigen-specific CD8 T cells by their recognition of several hundred candidate antigens simultaneously, as well as deeply characterizing their cellular phenotype. 

Read our white paper to find out how TargetScape™ can help lead to lower candidate attrition rates during clinical development, mitigate clinical trial failure risk, support overall drug development strategies and replenish your drug pipeline with new targets and improved drug candidates.

Read More
29th September 2019

Visit us at SITC 2019

November 6-10 | Prince Georges, MD

Talk with one of our scientists at booth 630
Take a look at our latest science at our Posters
(Abstract ID:P75 and P359)
Find out how partnering with us will fast forward your drug discovery and approval pipeline.

Stop by our booth to learn if you qualify for a highly discounted pilot program.

Read More